Save up -80% on Roflumilast

Note: this is a drug discount program, not an insurance plan.

RX BIN: 015558
RX PCN: HT
Group ID: DDN6600
Card Holder ID: DDN6600

Pharmacists and Patients support.

2018 Price of Roflumilast

$

* price without discount in nearest pharmacy. Price may vary.

Claim your free Roflumilast discount card

We offer free Roflumilast coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Roflumilast every time. What are you waiting for? Claim your prescription drug card now!

Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time

Roflumilast volume of distribution

Roflumilast has a Vd of 2.9L/kg with a dose of 500mcg. Permeability of roflumilast across the blood-brain barrier appears to be poor in rat studies.

About RX24Drugs

Discount Cards 16,000+

Clients Benefit 29%

Total savings $4,735,080

What is Roflumilast

Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor. Due to its selective inhibition of the PDE4 isoenzyme in lung cells, roflumilast is indicated for the management of chronic obstrtuctive pulmonary disease (COPD) exacerbations. Treatment with Roflumilast is associated with an increase in psychiatric adverse reactions, including suicide and suicidal attempts.

Roflumilast mechanism of action

Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor which, due to its selective inhibition of the PDE4 isoenzyme, has potential antiinflammatory and antimodulatory effects in the pulmonary system. It is thought that the increased levels of intracellular cyclic AMP are responsible for the therapeutic actions of Roflumilast.

Dosage forms of Roflumilast

FormRouteStrength
Tabletoral500 ug/1
Film-coated tabletOral use500 g
Tabletoral500 mcg
Prescription Generics

false

International Brands

Daliresp

Synonyms

Daliresp ROF

Manufacturers

Astra Zeneca Pharmaceuticals Lp

CAS number

162401-32-3

UNII

0P6C6ZOP5U

State

solid

Affected organisms

Humans and other mammals

Indication of Roflumilast

Roflumilast is indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. Roflumilast is not a bronchodilator and is not indicated for the relief of acute bronchospasm.

Toxicity of Roflumilast

Headache, weight loss, GI upset, insomnia, and loose stools.

RX24 Drugs Disclaimer: before buying a Roflumilast on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Roflumilast now!